Lista de obras -

A specific time course for mobilization of peripheral blood CD34+ cells after plerixafor injection in very poor mobilizer patients: impact on the timing of the apheresis procedure.

artículo científico publicado en 2012

Abnormal tongue ⬇️

artículo científico publicado el 13 de abril de 2011

Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes.

artículo científico publicado en 2016

CD34+stem cell top-ups without conditioning after initial haematopoietic stem cell transplantation for correction of incomplete haematopoietic and immunological recovery in severe congenital immunodeficiencies

artículo científico publicado en 2006

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome

artículo científico publicado en 2017

Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: a prospective observational cohort study ⬇️

artículo científico publicado el 6 de agosto de 2012

Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis

artículo científico publicado en 2007

First experience of autologous peripheral blood stem cell mobilization with biosimilar granulocyte colony- stimulating factor

article by François Lefrère et al published 10 March 2011 in Advances in Therapy

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

article

Gene Therapy in a Patient with Sickle Cell Disease

artículo científico publicado en 2017

Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene

artículo científico publicado en 2016

Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point of View.

artículo científico publicado en 2016

Hyperuricemia in sickle cell disease in France ⬇️

artículo científico publicado el 9 de septiembre de 2011

Plerixafor enables the safe, rapid, efficient mobilization of haematopoietic stem cells in sickle cell disease patients after exchange transfusion

artículo científico publicado en 2018

Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease

artículo científico publicado en 2018

Transfusion-related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease obs

artículo científico publicado en 2018

[Gene therapy for sickle cell disease]

artículo científico publicado en 2017

Lista de obras de

A specific time course for mobilization of peripheral blood CD34+ cells after plerixafor injection in very poor mobilizer patients: impact on the timing of the apheresis procedure.

Abnormal tongue ⬇️

Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes.

CD34+stem cell top-ups without conditioning after initial haematopoietic stem cell transplantation for correction of incomplete haematopoietic and immunological recovery in severe congenital immunodeficiencies

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome

Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: a prospective observational cohort study ⬇️

Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis

First experience of autologous peripheral blood stem cell mobilization with biosimilar granulocyte colony- stimulating factor

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

Gene Therapy in a Patient with Sickle Cell Disease

Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene

Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point of View.

Hyperuricemia in sickle cell disease in France ⬇️

Plerixafor enables the safe, rapid, efficient mobilization of haematopoietic stem cells in sickle cell disease patients after exchange transfusion

Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease

Transfusion-related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease obs

[Gene therapy for sickle cell disease]